Glucagon like peptide 1 (GLP 1) receptor agonists are incretin analogues that promote glucose mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP 1 receptor agonists and GLP 1 and glucose dependent insulinotropic Emerging Role of Dual GLP 1 and GIP Receptor Agonists DMSO Dove Medical Press Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare GLP1 Receptor Agonist Mechanisms GLP1RAs mimic the effects of Human Glucagon Like Peptide1 (GLP1), 'fooling your body' into thinking you ingested more than you actually have, causing earlier onset fullness & eventual Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Effects, working principles and target tissues of dual agonists Download Scientific Diagram